Literature DB >> 15710988

Bacterial biofilm within diseased pancreatic and biliary tracts.

A Swidsinski1, P Schlien, A Pernthaler, U Gottschalk, E Bärlehner, G Decker, S Swidsinski, J Strassburg, V Loening-Baucke, U Hoffmann, D Seehofer, L P Hale, H Lochs.   

Abstract

BACKGROUND: Bacterial community structures in human pancreatic and biliary tracts were evaluated.
METHODS: Gall bladder stones from 153 patients, 20 gall bladder walls, six common duct stones, 52 biliary stents, 21 duodenal biopsies, nine pancreatic duct biopsies, and five bile ducts were investigated using fluorescence in situ hybridisation (FISH) with ribosomal RNA targeted Cy3/Cy5 (carbocyanine) labelled oligonucleotide probes. RESULT: Duodenal, gall bladder, and bile duct walls were free of bacteria. A dense multispecies bacterial biofilm was present within the pancreatic duct of patients with calcific pancreatitis and within biliary stents, irrespective of diagnosis. The concentration, density, and amenability of the biofilm to FISH and DNA staining declined progressively with the grade of stent occlusion. The lowest detectable bacterial concentrations were found by FISH in completely occluded stents and brown/mixed gall stones. Bacteria were not detectable with FISH in cholesterol gall stones.
CONCLUSIONS: A wide range of different branches and groups of bacteria participate in the development of biofilms on the surfaces of foreign bodies, such as biliary stents, mixed gall stones, or calcific pancreatic ducts, but not on the surface of pure cholesterol gall stones. Occlusion of stents leads to progressive extinction of the biofilm and mummification of its components. Deposition of cholesterol or other substances within the biofilm matrix may be a novel mechanism of host defence against bacteria present in these biofilms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15710988      PMCID: PMC1774423          DOI: 10.1136/gut.2004.043059

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Specific oligonucleotide probes for in situ detection of a major group of gram-positive bacteria with low DNA G + C content.

Authors:  H Meier; R Amann; W Ludwig; K H Schleifer
Journal:  Syst Appl Microbiol       Date:  1999-05       Impact factor: 4.022

2.  Extensive set of 16S rRNA-based probes for detection of bacteria in human feces.

Authors:  Hermie J M Harmsen; Gerwin C Raangs; Tao He; John E Degener; Gjalt W Welling
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

Review 3.  Biofilm formation as microbial development.

Authors:  G O'Toole; H B Kaplan; R Kolter
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

4.  Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora.

Authors:  A Suau; V Rochet; A Sghir; G Gramet; S Brewaeys; M Sutren; L Rigottier-Gois; J Doré
Journal:  Syst Appl Microbiol       Date:  2001-04       Impact factor: 4.022

5.  Fluorescence in situ hybridization and catalyzed reporter deposition for the identification of marine bacteria.

Authors:  Annelie Pernthaler; Jakob Pernthaler; Rudolf Amann
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

Review 6.  The role of bacteria in gallstone pathogenesis.

Authors:  A Swidsinski; S P Lee
Journal:  Front Biosci       Date:  2001-10-01

7.  Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin-susceptible and clarithromycin-resistant Helicobacter pylori strains in gastric biopsies from children.

Authors:  A Feydt-Schmidt; H Rüssmann; N Lehn; A Fischer; I Antoni; D Störk; S Koletzko
Journal:  Aliment Pharmacol Ther       Date:  2002-12       Impact factor: 8.171

8.  Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups.

Authors:  H J Harmsen; A C Wildeboer-Veloo; J Grijpstra; J Knol; J E Degener; G W Welling
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

9.  Identification by in situ hybridization of segmented filamentous bacteria in the intestine of diarrheic rainbow trout (Oncorhynchus mykiss).

Authors:  M C Urdaci; B Regnault; P A Grimont
Journal:  Res Microbiol       Date:  2001 Jan-Feb       Impact factor: 3.992

10.  The application of biofilm science to the study and control of chronic bacterial infections.

Authors:  William Costerton; Richard Veeh; Mark Shirtliff; Mark Pasmore; Christopher Post; Garth Ehrlich
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

View more
  31 in total

Review 1.  Pancreaticobiliary biofilm: is cholesterol the answer?

Authors:  R A Kozarek
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

Review 2.  Antireflux biliary stents: are they the solution to stent occlusions?

Authors:  D Nageshwar Reddy; Rupa Banerjee; Ong Wai Choung
Journal:  Curr Gastroenterol Rep       Date:  2006-04

3.  Randomized trial in malignant biliary obstruction: plastic vs partially covered metal stents.

Authors:  Peter L Moses; Khalid M Alnaamani; Alan N Barkun; Stuart R Gordon; Roger D Mitty; M Stanley Branch; Thomas E Kowalski; Myriam Martel; Viviane Adam
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 4.  Microbiota, oral microbiome, and pancreatic cancer.

Authors:  Dominique S Michaud; Jacques Izard
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

5.  Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study.

Authors:  Xiaozhou Fan; Alexander V Alekseyenko; Jing Wu; Brandilyn A Peters; Eric J Jacobs; Susan M Gapstur; Mark P Purdue; Christian C Abnet; Rachael Stolzenberg-Solomon; George Miller; Jacques Ravel; Richard B Hayes; Jiyoung Ahn
Journal:  Gut       Date:  2016-10-14       Impact factor: 23.059

Review 6.  Microbiota dysbiosis in select human cancers: Evidence of association and causality.

Authors:  Jie Chen; Jada C Domingue; Cynthia L Sears
Journal:  Semin Immunol       Date:  2017-08-16       Impact factor: 11.130

7.  Disturbances of the Perioperative Microbiome Across Multiple Body Sites in Patients Undergoing Pancreaticoduodenectomy.

Authors:  Matthew B Rogers; Victoria Aveson; Brian Firek; Andrew Yeh; Brandon Brooks; Rachel Brower-Sinning; Jennifer Steve; Jillian F Banfield; Amer Zureikat; Melissa Hogg; Brian A Boone; Herbert J Zeh; Michael J Morowitz
Journal:  Pancreas       Date:  2017-02       Impact factor: 3.327

Review 8.  Biocompatible Polymer Materials with Antimicrobial Properties for Preparation of Stents.

Authors:  Kateřina Škrlová; Kateřina Malachová; Alexandra Muñoz-Bonilla; Dagmar Měřinská; Zuzana Rybková; Marta Fernández-García; Daniela Plachá
Journal:  Nanomaterials (Basel)       Date:  2019-10-31       Impact factor: 5.076

9.  Helicobacter species and common gut bacterial DNA in gallbladder with cholecystitis.

Authors:  Peren H Karagin; Unne Stenram; Torkel Wadström; Asa Ljungh
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

10.  Epithelial cells augment barrier function via activation of the Toll-like receptor 2/phosphatidylinositol 3-kinase pathway upon recognition of Salmonella enterica serovar Typhimurium curli fibrils in the gut.

Authors:  Gertrude O Oppong; Glenn J Rapsinski; Tiffanny N Newman; Jessalyn H Nishimori; Steven G Biesecker; Çagla Tükel
Journal:  Infect Immun       Date:  2012-12-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.